News >

Post-TURBT Gemcitabine Reduces Recurrence in Bladder Cancer

Angelica Welch
Published: Friday, May 26, 2017

Dr Edward Messing

Edward Messing, MD

Administering chemotherapy after transurethral resection of bladder tumor (TURBT) reduces the risk of recurrence, according to a paper presented at the American Urological Association’s 2017 Annual Meeting by lead author Edward Messing, MD.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Clinical Practice Connections™: New York Advanced Practice CollaborativeNov 15, 20191.25
Medical Crossfire®: Treating MS in the Modern Era: Right Patient, Right Treatment, Right TimeApr 20, 20201.5
Publication Bottom Border
Border Publication